Karolina Dolezalova1, Tomas Strachan2, Radoslav Matej3, Dita Ricna4, Marketa Bloomfield5. 1. Department of Paediatrics, First Faculty of Medicine, Charles University in Prague, Thomayer University Hospital, Prague, Czech Republic 2. National Institute of Child Tuberculosis and Respiratory Diseases, Dolny Smokovec, Slovakia 3. Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University in Prague, Thomayer University Hospital, Prague, Czech Republic 4. Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic 5. Department of Immunology, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czech Republic
Abstract
Background: Inborn errors of IL-12/IL-23-IFNγ immunity underlie Mendelian susceptibility to mycobacterial diseases (MSMD), a group of immunodeficiencies characterized by a highly selective susceptibility to weakly virulent strains of mycobacteria, such as non-tuberculous mycobacteria (NTM) and bacillus Calmette-Guérin (BCG). Cutaneous mycobacterial infections are common in MSMD and may represent a red flag for this immunodeficiency. Objectives: We present a case series of four paediatric patients with MSMD, specifically with IFNγR1 and STAT1 deficiencies, and cutaneous NTM/BCG infections to increase awareness of this immunodeficiency, which may, in some cases, be intercepted by the dermatologist and thus timely referred to the immunologist. Materials & Methods: Clinical, laboratory and genetic investigations of the four paediatric patients with MSMD are presented. Results: All four presented patients experienced early complications after BCG vaccination. Two patients suffered recurrent mycobacteriosis, one patient experienced delayed BCG reactivation, and one patient died of disseminated avian mycobacteriosis. The dermatological manifestation in these patients included destructive nasal ulcerations, scrofuloderma of various sites and lupus vulgaris. All patients had a normal basic immune phenotype. Conclusion: The presented cases demonstrate that NTM/BCG infections in otherwise seemingly immunocompetent patients should raise suspicion of MSMD. This is of utmost importance as specific therapeutic approaches, such as IFNγ treatment or haematopoietic stem cell transplantation, may be employed to improve the disease outcome.
Background: Inborn errors of IL-12/IL-23-IFNγ immunity underlie Mendelian susceptibility to mycobacterial diseases (MSMD), a group of immunodeficiencies characterized by a highly selective susceptibility to weakly virulent strains of mycobacteria, such as non-tuberculous mycobacteria (NTM) and bacillus Calmette-Guérin (BCG). Cutaneous mycobacterial infections are common in MSMD and may represent a red flag for this immunodeficiency. Objectives: We present a case series of four paediatric patients with MSMD, specifically with IFNγR1 and STAT1 deficiencies, and cutaneous NTM/BCG infections to increase awareness of this immunodeficiency, which may, in some cases, be intercepted by the dermatologist and thus timely referred to the immunologist. Materials & Methods: Clinical, laboratory and genetic investigations of the four paediatric patients with MSMD are presented. Results: All four presented patients experienced early complications after BCG vaccination. Two patients suffered recurrent mycobacteriosis, one patient experienced delayed BCG reactivation, and one patient died of disseminated avian mycobacteriosis. The dermatological manifestation in these patients included destructive nasal ulcerations, scrofuloderma of various sites and lupus vulgaris. All patients had a normal basic immune phenotype. Conclusion: The presented cases demonstrate that NTM/BCG infections in otherwise seemingly immunocompetent patients should raise suspicion of MSMD. This is of utmost importance as specific therapeutic approaches, such as IFNγ treatment or haematopoietic stem cell transplantation, may be employed to improve the disease outcome.
Entities:
Keywords:
MSMD; mendelian susceptibility to mycobacterial diseases; IFNγR1; STAT1; inborn error of immunity; non-tuberculous mycobacteria; BCG; necrotizing granulomas; antituberculotics
Authors: Carlos Franco-Paredes; Luis A Marcos; Andrés F Henao-Martínez; Alfonso J Rodríguez-Morales; Wilmer E Villamil-Gómez; Eduardo Gotuzzo; Alexandro Bonifaz Journal: Clin Microbiol Rev Date: 2018-11-14 Impact factor: 26.132
Authors: P Escalonilla; J Esteban; M L Soriano; M C Fariña; E Piqu; R Grilli; J R Ramírez; A Barat; L Martín; L Requena Journal: Clin Exp Dermatol Date: 1998-09 Impact factor: 3.470
Authors: Jerome A Lindeboom; Ed J Kuijper; Jan M Prins; Elisabeth S Bruijnesteijn van Coppenraet; Robert Lindeboom Journal: Clin Infect Dis Date: 2006-11-08 Impact factor: 9.079
Authors: Ashley B Wentworth; Lisa A Drage; Nancy L Wengenack; John W Wilson; Christine M Lohse Journal: Mayo Clin Proc Date: 2012-12-04 Impact factor: 7.616